Inogen (INGN) Reports Q1 EPS of $0.07; Boosts FY15 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Inogen (INGN) PT Lifted to $46 at Needham & Company
April 27, 2015 11:56 AM EDTNeedham & Company analyst Mike Matson reiterated a Strong Buy rating and bumped his price target on Inogen, Inc (NASDAQ: INGN) to $46.00 (from $45.00) following strong Q4 results.
Matson commented, "INGN beat consensus in 4Q14 and raised its 2015 revenue guidance. Growth remained strong across INGN's sales... More
